Lombard Odier Asset Management Switzerland SA Buys 16,700 Shares of Salesforce Inc. $CRM
Lombard Odier Asset Management Switzerland SA increased its stake in Salesforce Inc. (NYSE:CRM – Free Report) by 46.3% in the 4th quarter, Holdings Channel reports. The fund owned 52,750 shares of the CRM provider’s stock after buying an additional 16,700 shares during the quarter. Lombard Odier Asset Management Switzerland SA’s holdings in Salesforce were worth […]
Lombard Odier Asset Management Switzerland SA Sells 49,900 Shares of Citigroup Inc. $C
Lombard Odier Asset Management Switzerland SA reduced its position in Citigroup Inc. (NYSE:C – Free Report) by 35.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 91,392 shares of the company’s stock after selling 49,900 shares during the quarter. Lombard […]
Lombard Odier Asset Management Switzerland SA Acquires 4,200 Shares of T-Mobile US, Inc. $TMUS
Lombard Odier Asset Management Switzerland SA boosted its holdings in T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) by 20.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 25,065 shares of the Wireless communications provider’s stock after acquiring an additional 4,200 shares […]
Lombard Odier Asset Management Switzerland SA Grows Position in Intuitive Surgical, Inc. $ISRG
Lombard Odier Asset Management Switzerland SA lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 52.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 17,287 shares of the medical equipment provider’s stock after purchasing an additional […]
Pfizer Inc. $PFE Shares Acquired by Lombard Odier Asset Management Switzerland SA
Lombard Odier Asset Management Switzerland SA increased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 1,250.2% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 185,193 shares of the biopharmaceutical company’s stock after acquiring an additional 171,477 shares during […]
last updated on 17 Jun 15:35